Pharmabic Capsule 15 mg (Meloxicam)

Adult dose

1. Acute exacerbation of osteoarthritis (degenerative arthritis): ○ Adults: Administer 7.5 mg of meloxicam orally once daily. If symptoms do not improve, the dose may be increased to 15 mg per day as needed. 2. Rheumatoid arthritis, ankylosing spondylitis: ○ Adults: Administer 15 mg of this medicine orally once daily. The dose may be reduced to 7.5 mg per day depending on the response to treatment. This medicine should not be administered at doses exceeding 15 mg per day and should be taken with water or another beverage during a meal. ○ In elderly patients or those at increased risk of adverse reactions, treatment is usually started at a dose of 7.5 mg per day. ○ Patients with severe renal failure who are receiving hemodialysis should not be given more than 7.5 mg per day.

This medication may pose a risk of gastrointestinal bleeding for individuals who regularly consume more than three alcoholic drinks per day; thus, consultation with a doctor or pharmacist is essential. This medication may increase the risk of cardiovascular diseases, so caution is particularly required for individuals with a history or risk factors of heart disease or stroke. There can be serious problems like gastrointestinal bleeding, ulcers, or perforation with this medication, so individuals with a history of gastrointestinal disorders or the elderly should be closely monitored while using it. Severe allergic reactions or hypersensitivity may occur, therefore, discontinue use immediately if symptoms such as skin rash or mucosal damage appear. This medication can affect kidney and liver function, so individuals with kidney or liver disease should consult with healthcare professionals before use. This drug may reduce reproductive capability, so women planning pregnancy should refrain from using it. Individuals with a history of allergic reactions or asthma should be cautious, as serious respiratory issues may arise from taking this medication. This medication may affect blood clotting, therefore individuals with blood clotting disorders or those taking anticoagulants should follow their physician's guidance regarding its use. Symptoms such as blurred vision, dizziness, drowsiness may occur while taking this medication, so special care should be taken when driving or operating machinery. For those on long-term treatment, regular blood tests and liver and kidney function tests should be conducted to check for abnormalities. Drug interactions may occur, so it is important to inform healthcare professionals of any other medications being taken. Pregnant or breastfeeding women should not take this medication, especially in the later stages of pregnancy, as it may have severe effects on the fetus. Children and adolescents under 15 years of age should not take this medication. It is important to take this medication at the lowest effective dose and for the shortest duration to minimize the risk of side effects. Serious side effects can occur in the event of an overdose, so strict adherence to the prescribed dosage is essential, and in case of overdose, immediate medical attention should be sought. This medication should be kept out of reach of children and stored in its original container to maintain its quality.

• Gastrointestinal bleeding
• cardiovascular thrombotic reactions
• myocardial infarction
• stroke
• gastrointestinal or intestinal bleeding
• ulcers
• perforation
• exfoliative dermatitis
• mucosal epidermal necrolysis
• toxic epidermal necrolysis

This medication is sensitive to light and should be stored in a container that does not allow light in. Additionally, it is important to store it at a temperature between 1 to 30 degrees Celsius to maintain its effectiveness.

Appearance

A light yellow powder in an upper green and lower yellow capsule.

Package unit

30 capsules/bottle, 300 capsules/bottle